indications for glp 1 agonists The New Weight Management Meds Dosage of GLP-1 analogues |

Another clinical trial is in progress for Zepbound and its impact on cardiovascular disease

In clinical trials, Semaglutide GLP-1 was studied for up to 16 months for weight management

Only semaglutide, tirzepatide, and liraglutide are FDA approved for weight loss, but all of these medications are approved to treat type 2 diabetes

Pt A, Dec

45,46 In contrast, anorexigenic neurons suppress appetite by expressing proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) peptide

Additionally, they inhibit the secretion of glucagon, a hormone that raises blood sugar levels, and slow gastric emptying, leading to a prolonged feeling of fullness and reduced appetite